| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0 | 0.98 | Calcium antagonist | 0.86 0.001 DBMET01832 0.636 0.002 DBMET01833 | ||
| 0.98 | 0.002 | 0.98 | Vasodilator, coronary | 0.959 0.002 DBMET01832 0.639 0.006 DBMET01833 | ||
| 0.967 | 0.001 | 0.967 | Calcium channel blocker | 0.906 0.002 DBMET01832 0.893 0.002 DBMET01833 | ||
| 0.912 | 0.003 | 0.912 | Vasodilator, peripheral | 0.884 0.003 DBMET01832 0.706 0.006 DBMET01833 | ||
| 0.904 | 0.002 | 0.904 | Calcium channel (voltage-sensitive) blocker | 0.762 0.003 DBMET01832 0.743 0.003 DBMET01833 | ||
| 0.88 | 0.001 | 0.88 | Calcium channel L-type blocker | 0.811 0.001 DBMET01832 0.677 0.002 DBMET01833 | ||
| 0.679 | 0.003 | 0.724 | Calcium channel L-type activator | 0.724 0.002 DBMET01832 0.675 0.003 DBMET01833 | DBMET01832 | |
| 0.671 | 0.005 | 0.7 | Vasodilator | 0.7 0.004 DBMET01832 0.439 0.018 DBMET01833 | DBMET01832 | |
| 0.639 | 0.002 | 0.791 | Calcium channel activator | 0.791 0.001 DBMET01832 0.55 0.003 DBMET01833 | DBMET01832 | |
| 0.538 | 0.012 | 0.538 | Cardiotonic | 0.523 0.013 DBMET01832 0.34 0.042 DBMET01833 | ||
| 0.535 | 0.019 | 0.535 | Spasmolytic | 0.518 0.021 DBMET01832 0.239 0.096 DBMET01833 | ||
| 0.471 | 0.003 | 0.471 | TRPA1 agonist | 0.454 0.004 DBMET01832 0.157 0.027 DBMET01833 | ||
| 0.417 | 0.005 | 0.5 | Alpha 2b adrenoreceptor antagonist | 0.5 0.004 DBMET01832 0.249 0.015 DBMET01833 | DBMET01832 | |
| 0.401 | 0.022 | 0.421 | Sigma receptor agonist | 0.303 0.038 DBMET01832 0.421 0.019 DBMET01833 | DBMET01833 | |
| 0.373 | 0.004 | 0.373 | Adenylate kinase inhibitor | 0.29 0.007 DBMET01832 0.207 0.014 DBMET01833 | ||
| 0.379 | 0.02 | 0.379 | Cyclic AMP phosphodiesterase inhibitor | 0.336 0.029 DBMET01832 0.201 0.093 DBMET01833 | ||
| 0.32 | 0.005 | 0.358 | Alpha 2c adrenoreceptor antagonist | 0.358 0.005 DBMET01832 0.193 0.02 DBMET01833 | DBMET01832 | |
| 0.307 | 0.025 | 0.317 | 5 Hydroxytryptamine 1E antagonist | 0.317 0.02 DBMET01832 0.238 0.088 DBMET01833 | DBMET01832 | |
| 0.283 | 0.006 | 0.31 | Neuropeptide Y1 antagonist | 0.31 0.005 DBMET01832 0.224 0.012 DBMET01833 | DBMET01832 | |
| 0.278 | 0.026 | 0.278 | Lipocortins synthesis antagonist | 0.257 0.031 DBMET01832 0.225 0.043 DBMET01833 | ||
| 0.373 | 0.128 | 0.45 | DNA directed DNA polymerase inhibitor | 0.25 0.192 DBMET01832 0.45 0.097 DBMET01833 | DBMET01833 | |
| 0.202 | 0.014 | 0.289 | Alpha 1b adrenoreceptor antagonist | 0.289 0.008 DBMET01832 | DBMET01832 | |
| 0.215 | 0.029 | 0.237 | Acetylcholinesterase inhibitor | 0.103 0.101 DBMET01832 0.237 0.023 DBMET01833 | DBMET01833 | |
| 0.194 | 0.01 | 0.293 | Alpha 1d adrenoreceptor antagonist | 0.293 0.005 DBMET01832 0.052 0.047 DBMET01833 | DBMET01832 | |
| 0.204 | 0.031 | 0.524 | Anesthetic local | 0.242 0.022 DBMET01832 0.524 0.004 DBMET01833 | DBMET01833 | |
| 0.23 | 0.062 | 0.248 | Platelet aggregation inhibitor | 0.248 0.052 DBMET01832 | DBMET01832 | |
| 0.232 | 0.065 | 0.387 | Psychostimulant | 0.387 0.025 DBMET01832 | DBMET01832 | |
| 0.213 | 0.056 | 0.225 | P-glycoprotein inhibitor | 0.225 0.051 DBMET01832 0.177 0.082 DBMET01833 | DBMET01832 | |
| 0.312 | 0.159 | 0.386 | DNA polymerase beta inhibitor | 0.304 0.163 DBMET01832 0.386 0.125 DBMET01833 | DBMET01833 | |
| 0.171 | 0.018 | 0.197 | Alpha 2a adrenoreceptor antagonist | 0.197 0.014 DBMET01832 | DBMET01832 | |
| 0.183 | 0.034 | 0.211 | CF transmembrane conductance regulator agonist | 0.211 0.016 DBMET01832 | DBMET01832 | |
| 0.166 | 0.023 | 0.166 | Alpha 2 adrenoreceptor antagonist | 0.148 0.028 DBMET01832 | ||
| 0.192 | 0.05 | 0.198 | Cholinergic | 0.198 0.047 DBMET01833 | DBMET01833 | |
| 0.265 | 0.124 | 0.265 | Thioredoxin glutathione reductase inhibitor | 0.228 0.15 DBMET01832 0.253 0.132 DBMET01833 | ||
| 0.277 | 0.145 | 0.298 | Beta lactamase inhibitor | 0.22 0.173 DBMET01832 0.298 0.135 DBMET01833 | DBMET01833 | |
| 0.2 | 0.074 | 0.252 | Anesthetic general | 0.244 0.053 DBMET01832 0.252 0.05 DBMET01833 | DBMET01833 | |
| 0.144 | 0.024 | 0.151 | Toll-Like receptor 4 antagonist | 0.125 0.039 DBMET01832 0.151 0.02 DBMET01833 | DBMET01833 | |
| 0.138 | 0.041 | 0.144 | Alpha adrenoreceptor antagonist | 0.144 0.039 DBMET01832 | DBMET01832 | |
| 0.137 | 0.046 | 0.14 | Calcium channel N-type blocker | 0.099 0.097 DBMET01832 0.14 0.044 DBMET01833 | DBMET01833 | |
| 0.231 | 0.141 | 0.339 | Transcription factor NF kappa B inhibitor | 0.339 0.08 DBMET01832 | DBMET01832 | |
| 0.102 | 0.015 | 0.102 | Calcium channel T-type blocker | 0.054 0.047 DBMET01832 | ||
| 0.098 | 0.017 | 0.138 | Beta adrenoreceptor antagonist | 0.138 0.007 DBMET01832 | DBMET01832 | |
| 0.113 | 0.039 | 0.147 | Alpha 1 adrenoreceptor antagonist | 0.147 0.03 DBMET01832 | DBMET01832 | |
| 0.117 | 0.047 | 0.152 | Antiadrenergic | 0.152 0.035 DBMET01832 | DBMET01832 | |
| 0.084 | 0.015 | 0.107 | Potassium channel intermediate-conductance Ca-activated blocker | 0.107 0.007 DBMET01832 0.059 0.044 DBMET01833 | DBMET01832 | |
| 0.114 | 0.046 | 0.147 | Adrenaline antagonist | 0.147 0.035 DBMET01832 | DBMET01832 | |
| 0.101 | 0.036 | 0.155 | Alpha 1a adrenoreceptor antagonist | 0.155 0.023 DBMET01832 | DBMET01832 | |
| 0.127 | 0.062 | 0.217 | Alkylator | 0.217 0.022 DBMET01832 0.163 0.04 DBMET01833 | DBMET01832 | |
| 0.227 | 0.166 | 0.227 | Calpain 2 inhibitor | 0.217 0.173 DBMET01832 | ||
| 0.167 | 0.112 | 0.183 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.183 0.09 DBMET01833 | DBMET01833 | |
| 0.069 | 0.015 | 0.08 | Mineralocorticoid receptor antagonist | 0.08 0.011 DBMET01832 | DBMET01832 | |
| 0.147 | 0.093 | 0.156 | Interleukin 6 antagonist | 0.147 0.093 DBMET01832 0.156 0.081 DBMET01833 | DBMET01833 | |
| 0.096 | 0.043 | 0.096 | Neuropeptide Y antagonist | 0.087 0.05 DBMET01832 | ||
| 0.108 | 0.056 | 0.115 | Butyrylcholinesterase inhibitor | 0.115 0.05 DBMET01833 | DBMET01833 | |
| 0.125 | 0.078 | 0.221 | Toll-Like receptor antagonist | 0.197 0.032 DBMET01832 0.221 0.024 DBMET01833 | DBMET01833 | |
| 0.073 | 0.029 | 0.082 | Nitric oxide donor | 0.082 0.02 DBMET01832 | DBMET01832 | |
| 0.204 | 0.161 | 0.258 | Cholesterol antagonist | 0.258 0.119 DBMET01833 | DBMET01833 | |
| 0.149 | 0.108 | 0.165 | Catenin beta inhibitor | 0.165 0.074 DBMET01833 | DBMET01833 | |
| 0.086 | 0.047 | 0.086 | Glycine receptor antagonist | 0.082 0.054 DBMET01832 | ||
| 0.061 | 0.025 | 0.107 | Nicotinic alpha3beta2 receptor antagonist | 0.107 0.006 DBMET01832 0.056 0.032 DBMET01833 | DBMET01832 | |
| 0.066 | 0.03 | 0.103 | Beta 1 adrenoreceptor antagonist | 0.103 0.009 DBMET01832 | DBMET01832 | |
| 0.06 | 0.025 | 0.077 | Dopamine transporter inhibitor | 0.077 0.018 DBMET01832 | DBMET01832 | |
| 0.079 | 0.044 | 0.101 | Adenosine A3 receptor antagonist | 0.101 0.026 DBMET01832 | DBMET01832 | |
| 0.106 | 0.073 | 0.11 | Platelet activating factor antagonist | 0.11 0.07 DBMET01832 | DBMET01832 | |
| 0.086 | 0.059 | 0.086 | Ca(v)2.2 blocker | |||
| 0.1 | 0.078 | 0.126 | Multidrug resistance-associated protein 1 inhibitor | 0.126 0.042 DBMET01833 | DBMET01833 | |
| 0.065 | 0.044 | 0.069 | 5 Hydroxytryptamine 1D antagonist | 0.069 0.04 DBMET01832 | DBMET01832 | |
| 0.055 | 0.036 | 0.065 | Thromboxane synthase inhibitor | 0.065 0.022 DBMET01832 | DBMET01832 | |
| 0.035 | 0.019 | 0.04 | Transforming growth factor beta 2 antagonist | 0.04 0.012 DBMET01832 | DBMET01832 | |
| 0.155 | 0.139 | 0.191 | Platelet antagonist | 0.191 0.108 DBMET01832 | DBMET01832 | |
| 0.058 | 0.043 | 0.061 | Gonadotropin-releasing hormone receptor agonist | 0.061 0.038 DBMET01833 | DBMET01833 | |
| 0.222 | 0.208 | 0.237 | Transcription factor inhibitor | 0.233 0.199 DBMET01832 0.237 0.196 DBMET01833 | DBMET01833 | |
| 0.056 | 0.043 | 0.056 | Dopamine uptake inhibitor | |||
| 0.092 | 0.08 | 0.108 | Mediator release inhibitor | 0.108 0.061 DBMET01832 | DBMET01832 | |
| 0.079 | 0.067 | 0.094 | Androgen antagonist | 0.094 0.051 DBMET01832 | DBMET01832 | |
| 0.195 | 0.184 | 0.267 | Antithrombotic | 0.267 0.113 DBMET01832 | DBMET01832 | |
| 0.139 | 0.132 | 0.194 | Non-steroidal antiinflammatory agent | 0.194 0.076 DBMET01832 0.163 0.101 DBMET01833 | DBMET01832 | |
| 0.183 | 0.175 | 0.217 | Hypoxia-inducible factor 1 alpha inhibitor | 0.217 0.132 DBMET01832 | DBMET01832 | |
| 0.044 | 0.039 | 0.067 | Aldosterone antagonist | 0.067 0.015 DBMET01832 | DBMET01832 | |
| 0.134 | 0.129 | 0.164 | Hepatoprotectant | 0.164 0.095 DBMET01832 | DBMET01832 | |
| 0.148 | 0.147 | 0.191 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.191 0.098 DBMET01833 | DBMET01833 | |
| 0.046 | 0.045 | 0.048 | Sodium/calcium exchanger inhibitor | 0.048 0.038 DBMET01832 | DBMET01832 | |
| 0.161 | 0.165 | 0.236 | Peptidyltransferase inhibitor | 0.236 0.061 DBMET01832 | DBMET01832 | |
| 0.124 | 0.131 | 0.151 | Amyloid beta aggregation inhibitor | 0.151 0.107 DBMET01833 | DBMET01833 | |
| 0.149 | 0.156 | 0.168 | MAP kinase kinase 5 inhibitor | 0.168 0.092 DBMET01833 | DBMET01833 | |
| 0.207 | 0.216 | 0.281 | Alpha-glucosidase inhibitor | 0.281 0.17 DBMET01833 | DBMET01833 | |
| 0.08 | 0.089 | 0.091 | Phosphodiesterase 7B inhibitor | 0.091 0.068 DBMET01833 | DBMET01833 | |
| 0.05 | 0.059 | 0.102 | Adrenaline uptake inhibitor | 0.102 0.018 DBMET01832 | DBMET01832 | |
| 0.043 | 0.053 | 0.055 | Squalene epoxidase inhibitor | 0.055 0.027 DBMET01833 | DBMET01833 | |
| 0.034 | 0.045 | 0.05 | Phosphorylase inhibitor | 0.05 0.03 DBMET01832 | DBMET01832 | |
| 0.044 | 0.057 | 0.061 | Glutamate (mGluR1) antagonist | 0.061 0.038 DBMET01833 | DBMET01833 | |
| 0.112 | 0.124 | 0.128 | Farnesoid X receptor antagonist | 0.128 0.087 DBMET01832 | DBMET01832 | |
| 0.072 | 0.091 | 0.084 | Thioredoxin reductase inhibitor | 0.077 0.071 DBMET01832 0.084 0.053 DBMET01833 | DBMET01833 | |
| 0.063 | 0.087 | 0.092 | Interferon agonist | 0.092 0.036 DBMET01833 | DBMET01833 | |
| 0.07 | 0.101 | 0.092 | Interleukin 5 antagonist | 0.092 0.051 DBMET01833 | DBMET01833 | |
| 0.103 | 0.136 | 0.127 | Acetylcholine M1 receptor antagonist | 0.127 0.099 DBMET01833 | DBMET01833 | |
| 0.078 | 0.113 | 0.092 | Chelator | 0.092 0.09 DBMET01833 | DBMET01833 | |
| 0.097 | 0.133 | 0.151 | Interleukin 1 antagonist | 0.151 0.056 DBMET01833 | DBMET01833 | |
| 0.05 | 0.087 | 0.069 | Interferon inducer | 0.069 0.036 DBMET01833 | DBMET01833 | |
| 0.036 | 0.076 | 0.063 | 5 Hydroxytryptamine uptake inhibitor | 0.063 0.044 DBMET01832 | DBMET01832 | |
| 0.09 | 0.132 | 0.15 | Toll-Like receptor 9 antagonist | 0.15 0.063 DBMET01832 0.112 0.096 DBMET01833 | DBMET01832 | |
| 0.098 | 0.14 | 0.149 | Diuretic | 0.149 0.078 DBMET01832 | DBMET01832 | |
| 0.035 | 0.082 | 0.057 | Myc inhibitor | 0.057 0.034 DBMET01832 | DBMET01832 | |
| 0.062 | 0.11 | 0.075 | Glutathione S-transferase inhibitor | 0.075 0.07 DBMET01832 | DBMET01832 | |
| 0.048 | 0.097 | 0.057 | Bcl-xL inhibitor | 0.057 0.05 DBMET01833 | DBMET01833 | |
| 0.149 | 0.213 | 0.267 | Thyroid hormone antagonist | 0.267 0.112 DBMET01833 | DBMET01833 | |
| 0.03 | 0.104 | 0.05 | Benzodiazepine antagonist | 0.05 0.026 DBMET01833 | DBMET01833 | |
| 0.076 | 0.154 | 0.106 | Photosensitizer | 0.106 0.078 DBMET01832 | DBMET01832 | |
| 0.139 | 0.218 | 0.256 | Thyroid hormone beta antagonist | 0.256 0.115 DBMET01833 | DBMET01833 | |
| 0.111 | 0.193 | 0.153 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.153 0.139 DBMET01833 | DBMET01833 | |
| 0.041 | 0.126 | 0.062 | Bcl2 antagonist | 0.062 0.052 DBMET01833 | DBMET01833 | |
| 0.066 | 0.154 | 0.15 | Toll-Like receptor 3 antagonist | 0.15 0.014 DBMET01832 | DBMET01832 | |
| 0.049 | 0.137 | 0.071 | Calcium channel P-type blocker | 0.071 0.027 DBMET01833 | DBMET01833 | |
| 0.02 | 0.115 | 0.037 | Glutamate (mGluR1a) antagonist | 0.037 0.033 DBMET01832 | DBMET01832 | |
| 0.123 | 0.22 | 0.297 | DNA damaging | 0.198 0.117 DBMET01832 0.297 0.058 DBMET01833 | DBMET01833 | |
| 0.094 | 0.199 | 0.138 | Dual specificity phosphatase inhibitor | 0.138 0.108 DBMET01833 | DBMET01833 | |
| 0.075 | 0.181 | 0.119 | Interleukin 4 antagonist | 0.119 0.087 DBMET01833 | DBMET01833 | |
| 0.057 | 0.165 | 0.08 | Transcription factor NF kappa B stimulant | 0.08 0.07 DBMET01832 | DBMET01832 | |
| 0.19 | 0.308 | 0.254 | MAP kinase 1 inhibitor | 0.254 0.229 DBMET01832 0.249 0.235 DBMET01833 | DBMET01832 | |
| 0.022 | 0.155 | 0.05 | Beta 2 adrenoreceptor antagonist | 0.05 0.036 DBMET01832 | DBMET01832 | |
| 0.044 | 0.179 | 0.084 | Viral attachment inhibitor | 0.084 0.042 DBMET01833 | DBMET01833 | |
| 0.07 | 0.206 | 0.139 | Antibacterial (Helicobacter pylori) | 0.139 0.057 DBMET01833 | DBMET01833 | |
| 0.043 | 0.179 | 0.096 | Potassium channel activator | 0.096 0.052 DBMET01832 | DBMET01832 | |
| 0.076 | 0.215 | 0.135 | Dual specificity phosphatase 3 inhibitor | 0.135 0.111 DBMET01833 | DBMET01833 | |
| 0.048 | 0.188 | 0.109 | Breast cancer-resistant protein inhibitor | 0.109 0.048 DBMET01833 | DBMET01833 | |
| 0.038 | 0.194 | 0.12 | M18 aspartyl aminopeptidase inhibitor | 0.12 0.071 DBMET01832 | DBMET01832 | |
| 0.059 | 0.216 | 0.122 | Cytidine deaminase inhibitor | 0.122 0.098 DBMET01833 | DBMET01833 | |
| 0.114 | 0.273 | 0.197 | 12-Lipoxygenase inhibitor | 0.197 0.155 DBMET01833 | DBMET01833 | |
| 0.163 | 0.333 | 0.236 | Apoptosis agonist | 0.236 0.229 DBMET01832 | DBMET01832 | |
| 0.023 | 0.198 | 0.044 | Potassium channel (ATP-sensitive) activator | 0.044 0.043 DBMET01832 | DBMET01832 | |
| 0.077 | 0.253 | 0.107 | DNA repair enzyme inhibitor | 0.107 0.105 DBMET01833 | DBMET01833 | |
| 0.024 | 0.201 | 0.046 | Potassium channel (Inward rectifier) activator | 0.046 0.044 DBMET01832 | DBMET01832 | |
| 0.055 | 0.237 | 0.138 | Cytokine production inhibitor | 0.138 0.072 DBMET01833 | DBMET01833 | |
| 0.077 | 0.263 | 0.153 | GABA C receptor rho-2 antagonist | 0.153 0.069 DBMET01832 | DBMET01832 | |
| 0.068 | 0.291 | 0.146 | Platelet adhesion inhibitor | 0.146 0.11 DBMET01833 | DBMET01833 | |
| 0.161 | 0.391 | 0.308 | Caspase 9 stimulant | 0.308 0.186 DBMET01833 | DBMET01833 | |
| 0.087 | 0.37 | 0.2 | Gastrin inhibitor | 0.2 0.149 DBMET01832 | DBMET01832 | |
| 0.074 | 0.401 | 0.151 | Histone acetyltransferase inhibitor | 0.151 0.138 DBMET01833 | DBMET01833 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |